Results 261 to 270 of about 172,791 (358)

Expression of p53 Protein Before and After PUVA Treatment in Psoriasis

, 1999
Anna Hannuksela‐Svahn, Paavo Pääkkö, Pekka Autio, Timo Reunala, Jaakko Karvonen, Kirsi Vähäkangas   +5 more
openalex   +1 more source

A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses

Medicinal Research Reviews, EarlyView.
ABSTRACT Autophagy is a highly conserved intracellular process involved in maintaining homeostasis and in the degradation of damaged organelles and external pathogens. Nature provides complex and varied reservoirs of scaffolds and chemical entities that may have a pivotal role in the search for new therapeutic leads.
Ilaria Cursaro, Sara Rossi, Stefania Butini, Sandra Gemma, Gabriele Carullo, Giuseppe Campiani   +5 more
wiley   +1 more source

Nano-based formulations of thymoquinone are new approaches for psoriasis treatment: a literature review. [PDF]

Front Immunol
Modarresi Chahardehi A, Ojaghi HR, Motedayyen H, Arefnezhad R.   +3 more
europepmc   +1 more source

Patient Needs in Psoriasis Treatment and their Influencing Factors: A Nationwide Multicentre Cross-Sectional Study in China.

Indian J Dermatol, 2023
Ding W, Yao M, Wang Y, Wang M, Zhu Y, Li Y, Li Z, Li L, Ma W, Liu M, Zhou N.   +10 more
europepmc   +1 more source

Levels of Skin-Derived Antileukoproteinase (SKALP)/Elafin in Serum Correlate with Disease Activity During Treatment of Severe Psoriasis with Cyclosporin A

, 1995
Hans Alkemade, Gijs J. De Jongh, W.P. Arnold, P.C.M. van de Kerkhof, Joost Schalkwijk   +4 more
openalex   +1 more source

Anti‐Inflammatory Saponins From an Edible Aquatic Plant Nymphoides hydrophylla

Phytochemical Analysis, EarlyView.
ABSTRACT Introduction The present investigation of Nymphoides hydrophylla is a Taiwan indigenous edible aquatic plant, belongs to the Menyanthaceae family, and has been used as a traditional food with potential medicinal values against fever, insect bites, ulcer, and skin diseases.
Ching‐Yeu Chen, Tzu‐Peng Cheng, Tsong‐Long Hwang, Yong‐Siang Hou, Limbadri Salendra, Tzi‐Yi Ke, Yuan‐Bin Cheng   +6 more
wiley   +1 more source

CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway. [PDF]

Stem Cell Res Ther
Xiao Q, Chu W, Guo J, Gao J, Yao W, Huang M, Lu Y, Xu Q, Xu N.   +8 more
europepmc   +1 more source

Low Dose Cyclosporin A and Methotrexate in the Treatment of Psoriasis

, 1999
Katherine Georgouras Kenneth C. Wong
openalex   +1 more source

Continuous‐Time Markov Population PK/PD Modeling of Longitudinal EASI Categorical Score in Atopic Dermatitis Treated With Rocatinlimab, an Anti‐OX40 Monoclonal Antibody

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Rocatinlimab (AMG 451/KHK4083) is a potential T‐cell rebalancing therapy that inhibits and reduces the number of pathogenic T cells by targeting the OX40 receptor; it is associated with a progressive and sustained response for patients with moderate‐to‐severe atopic dermatitis (AD).
Hiroki Okada, Sam Liao, Lisa Khouri, Lori Liao, Matthew W. Hruska, Yoshinori Nagata, Maki Hasegawa, Andrew Gewitz, Douglas Marsteller   +8 more
wiley   +1 more source

Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13-year retrospective study. [PDF]

J Dermatol
Koyama A, Li L, Yamamoto T, Taira H, Sugimoto E, Ito Y, Mizuno Y, Awaji K, Tateishi S, Kanda H, Sato S, Shibata S.   +11 more
europepmc   +1 more source